e.g. Tata motors, Reliance MF, 500570

Bafna Pharmaceuticals Ltd. - Research Center

532989 BAFNAPH Group (T) BSE data
 
Back to Company Page
Results:

Half yearly results in brief

(Rs crore)
Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Sales 73.61 82.63 38.89 35.44 49.70
Operating profit 5.00 10.30 4.20 2.31 9.18
Interest 1.27 1.04 0.76 0.58 0.22
Gross profit 5.26 11.29 5.38 3.49 9.31
EPS (Rs) 0.80 3.73 1.26 0.29 1.89

Half yearly  results in details

Sep ' 24 Sep ' 23 Sep ' 22 Mar ' 22 Sep ' 21
Other income 1.53 2.03 1.94 1.76 0.35
Stock adjustment 1.45 -1.28 -2.22 1.00 -2.78
Raw material 40.18 39.23 26.46 21.02 32.04
Power and fuel - - - - -
Employee expenses 10.19 9.12 7.24 7.35 7.16
Excise - - - - -
Admin and selling expenses - - - - -
Research and development expenses - - - - -
Expenses capitalised - - - - -
Other expenses 16.78 25.26 3.21 3.76 4.10
Provisions made - - - - -
Depreciation 3.02 2.45 2.41 2.61 2.88
Taxation - - - - -
Net profit / loss 1.89 8.83 2.97 0.69 4.46
Extra ordinary item -0.35 - - -0.19 -1.97
Prior year adjustments - - - - -
Equity capital 23.66 23.66 23.66 23.66 23.66
Equity dividend rate - - - - -
Agg.of non-prom. shares (Lacs) - - - - -
Agg.of non promotoholding (%) - - - - -
OPM (%) 6.80 12.46 10.80 6.52 18.47
GPM (%) 7.00 13.33 13.18 9.38 18.61
NPM (%) 2.52 10.44 7.28 1.85 8.92
Close
Add Bafna Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Bafna Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback